Goles, Nerie G.
HRN: 27 22 01 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/19/2025
CEFTAZIDIME 1GM (VIAL)
07/19/2025
08/01/2025
IV
1gm
Q8
Vap
Pending Pharmacy Acceptance
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: